Gemcitabine-associated acute lipodermatosclerosislike eruption: An underrecognized phenomenon

Gemcitabine-associated acute lipodermatosclerosislike eruption: An underrecognized phenomenon

Bibliographic Details
Main Authors:	Amit Mittal, BA, Jonathan S. Leventhal, MD
Format:	Article
Language:	English
Published:	Elsevier 2017-05-01
Series:	JAAD Case Reports
Subjects:	acute lipodermatosclerosis gemcitabine pseudocellulitis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512617300474

Similar Items

Pseudocellulitis in oncology patients: A single institutional retrospective analysis investigating the clinical presentation, therapeutic response, and implications for cancer therapy
by: Jolanta J. Pach, BS, et al.
Published: (2023-09-01)

Acute inflammatory edema in the setting of bilateral lung transplantation
by: Scott McGaugh, BA, et al.
Published: (2023-02-01)

Role of vascular ultrasound in cases of lower limb hyperpigmentation
by: Himanshu Kumar, et al.
Published: (2019-01-01)

Acute Inflammatory Edema: A Case Report with Histopathological and Immunohistochemical Findings
by: Chirasuthat P, et al.
Published: (2021-09-01)

The response of skin hardness and pain sensation to ultrasonic treatment in lipodermatosclerosis patients
by: Shaimaa A. Hamid, et al.
Published: (2014-04-01)

The use of high-frequency skin ultrasound in the diagnosis of lipodermatosclerosis
by: Woźniak Witold, et al.
Published: (2020-01-01)

Gemcitabine-induced coronary vasospasm: A case report
by: Mahmut Tuna Katırcıbaşı, et al.
Published: (2017-03-01)

Cardiotoxicity caused by gemcitabine
by: Yuri Isaakyan, et al.
Published: (2023-01-01)

Gemcitabine-related pulmonary toxicity
by: A Gunz, et al.
Published: (2002-01-01)

Panniculitis in rheumatology: features of course and outcomes
by: N M Savushkina, et al.
Published: (2018-05-01)

Comparing skin surface temperature to clinical documentation of skin warmth in emergency department patients diagnosed with cellulitis
by: Edward Harwick, et al.
Published: (2022-04-01)

Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?
by: Jie Xu, et al.
Published: (2018-10-01)

Recent Advances in Lipid-Based Nanosystems for Gemcitabine and Gemcitabine–Combination Therapy
by: Saffiya Habib, et al.
Published: (2021-02-01)

Acute generalized exanthematous pustulosis caused by gemcitabine after nivolumab in metastatic lung adenocarcinoma followed by a dramatic tumor response: A case report
by: Pierre Magdelaine, et al.
Published: (2022-07-01)

Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapy
by: Limviphuvadh, Vachiranee, et al.
Published: (2018)

THE DIFFERENCES OF APOPTOSIS EFFECTS BETWEEN COMBINATION OF MELOXICAM WITH GEMCITABINE-CARBOPLATIN CHEMOTHERAPY COMPARED TO GEMCITABINE-CARBOPLATIN CHEMOTHERAPY ALONE IN UROTHELIAL CARCINOMA CULTURE CELLS
by: Ananta Cahyo Nugroho, et al.
Published: (2019-01-01)

Posterior Reversible Leukoencephalopathy Secondary to Gemcitabine
by: Aslan Tekataş, et al.
Published: (2014-03-01)

COMPARISON BETWEEN GEMCITABINE-CARBOPLATIN AND COMBINATION OF GEMCITABINE-CARBOPLATIN AND CELECOXIB IN UROTHELIAL CARCINOMA CELL APOPTOSIS
by: Widya Sakti Pratama, et al.
Published: (2019-01-01)

Concurrent Chemoradiation With Weekly Gemcitabine and Cisplatin in Locally Advanced Cervical Cancer
by: Esmati E, et al.
Published: (2011-12-01)

Conventional chemoradiation with Cisplatin Versus hemoradiation with Cisplatin plus Gemcitabine in uterine cervical cancer
by: Ahmad Ameri (MD), et al.
Published: (2008-10-01)

Recent Development of Prodrugs of Gemcitabine
by: Bhoomika Pandit, et al.
Published: (2022-03-01)

Pancreatic Cancer Chemoresistance to Gemcitabine
by: Manoj Amrutkar, et al.
Published: (2017-11-01)

A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma
by: Ma Yue, et al.
Published: (2011-03-01)

Gemcitabine induced pneumonitis: a case report and review of literature
by: Nishanth Thalambedu, et al.
Published: (2020-11-01)

Gemcitabine-Induced Cardiotoxicity in Patients Receiving Adjuvant Chemotherapy for Pancreatic Cancer: A Case Series
by: Salma Alam, et al.
Published: (2018-04-01)

Induction gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinoma
by: Yuan Zhang, et al.
Published: (2019-06-01)

Tissue distribution of crizotinib and gemcitabine combination in a patient-derived orthotopic mouse model of pancreatic cancer
by: Richard J. Honeywell, et al.
Published: (2016-12-01)

Gemcitabine and Rapamycin Exhibit Additive Effect against Osteosarcoma by Targeting Autophagy and Apoptosis
by: Takashi Ando, et al.
Published: (2020-10-01)

Gemcitabine Combination Nano Therapies for Pancreatic Cancer
by: Kamalika Samanta, et al.
Published: (2019-11-01)

Role of Maintenance Gemcitabine in Advanced Carcinoma Gallbladder
by: Manish Sharma, et al.
Published: (2020-10-01)

Randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine and nanoparticle albumin-bound paclitaxel combination therapy as neoadjuvant chemotherapy for resectable/borderline resectable pancreatic ductal adenocarcinoma (PDAC-GS/GA-rP2, CSGO-HBP-015)
by: Daisaku Yamada, et al.
Published: (2021-08-01)

Administration of Gemcitabine for Metastatic Adenocarcinoma during Pregnancy: A Case Report and Review of the Literature
by: M. Wiesweg, et al.
Published: (2014-02-01)

Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck
by: Ammar Sukari, et al.
Published: (2015-04-01)

Gemcitabine-Resistant Biomarkers in Bladder Cancer are Associated with Tumor-Immune Microenvironment
by: Yuxuan Song, et al.
Published: (2022-01-01)

Toxic Effects of Gemcitabine and Paclitaxel Combination: Chemotherapy Drugs Exposure in Zebrafish
by: Claudio D’Iglio, et al.
Published: (2023-06-01)

Comparison of gemcitabine and anthracycline antibiotics in prevention of superficial bladder cancer recurrence
by: Tian-Wei Wang, et al.
Published: (2019-10-01)

Cardiotoxicity Associated with Gemcitabine: Literature Review and a Pharmacovigilance Study
by: Marc Hilmi, et al.
Published: (2020-10-01)

Cell-Cycle Synchronization Prior to Radiotherapy: A Mathematical Model of the Use of Gemcitabine on Melanoma Xenografts
by: Frederika Rentzeperis, et al.
Published: (2024-02-01)

Efficacy of Eribulin Plus Gemcitabine Combination in L-Sarcomas
by: María López-Álvarez, et al.
Published: (2022-12-01)

microRNAs Associated with Gemcitabine Resistance via EMT, TME, and Drug Metabolism in Pancreatic Cancer
by: Naotake Funamizu, et al.
Published: (2023-02-01)